Plus, Reddit's first-ever earnings.
Plus, Lucid keeps losing money.
Plus, J&J's new cancer drug results.
Time to buy? The scoop on Zoom.
Plus, Coinbase's "elevated expenses."
Plus, Carvana's surprise Q1 profit.
Plus, AMD's AI chip sales forecast.
And, MicroStrategy’s impairment loss.
Plus, NEAR Protocol’s AI jump stops.
Your Snap stock gameplan.
Plus, Microsoft's cloud strength.
Plus, IBM's next big tech acquisition.
